First Quadrant’s Altimmune ALT Stock Holding History

First Quadrant’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,385	Closed	-$202K	–	817
2017 Q4	$202K	Sell	3,385 -43	-1%	-$2.75K	﹤0.01%	720
2017 Q3	$239K	Sell	3,428 -856	-20%	-$63.7K	﹤0.01%	675
2017 Q2	$411K	Sell	4,284 -1,234	-22%	-$205K	0.01%	571
2017 Q1	$1.34M	Buy	5,518 +5,419	+5,474%	+$2.9M	0.03%	411
2016 Q4	$96K	Hold	99	–	–	﹤0.01%	704
2016 Q3	$86K	Buy	+99	New	+$77.7K	﹤0.01%	739

Other funds holding ALT

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

LIM

Leavell Investment Management Mobile, Alabama $2.74B AUM 26.51% 1-Year Est. Return

First Quadrant's ALT Position: Q1 2018 in Review

First Quadrant sold out of Altimmune (ALT) in Q1 2018, closing a stake of 3,385 shares — an estimated $202K sold.

First Quadrant first reported a position in ALT in Q3 2016 and held it in 6 quarters. The position peaked at $1.34M in Q1 2017. 26 funds tracked by Wall St. Rank hold ALT as of Q1 2018.

First Quadrant reported no remaining Altimmune position as of Q1 2018 after selling out during the quarter.
First Quadrant sold 3,385 Altimmune shares in Q1 2018, an estimated $202K.
First Quadrant first reported a position in Altimmune in Q3 2016 and held it in 6 quarters.
First Quadrant's Altimmune position peaked at $1.34M in Q1 2017.
26 funds tracked by Wall St. Rank held Altimmune as of Q1 2018.

Based on First Quadrant's 13F filing for Q1 2018, filed 20 Apr 2018.